FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Victanyl 25micrograms/hour transdermal patches (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Victanyl 50micrograms/hour transdermal patches (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Victanyl 100micrograms/hour transdermal patches (Accord Healthcare Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Victanyl 50micrograms/hour transdermal patches (Accord Healthcare Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Victanyl 25micrograms/hour transdermal patches (Accord Healthcare Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Victanyl 75micrograms/hour transdermal patches (Accord Healthcare Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely amiloride hydrochloride 5 milligram and bumetanide 1 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine hydrochloride 200mg capsules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Aprotinin 10,000iu/mL injection solution 50mL vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely thioridazine hydrochloride 100 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Human normal immunoglobulin 6g infusion solution vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Synovial fluid 20mg/ml injection 2ml pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normal immunoglobulin human 12g powder and solvent for solution for injection bottles VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Keromask finishing powder translucent VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Keromask masking cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely mexiletine hydrochloride 50 milligram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely deflazacort 1 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely ganciclovir 1.5 milligram/1 gram conventional release eye gel VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 5,000units/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amiloride 5mg / Bumetanide 1mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 5,000units/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amiloride 5mg / Bumetanide 1mg tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Lepicol powder VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Berocca effervescent tablets sugar free 45 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely prochlorperazine maleate 5 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely prochlorperazine maleate 25 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glycerol 750mg/5ml oral solution VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Sominex Herbal tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zinc compound paste VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melgisorb Ag dressing 15cm x 15cm (Molnlycke Health Care Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Altiform class III below knee stocking circular knit made to measure closed toe Soft beige (Altimed Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SeaSorb Ag dressing 15cm x 15cm (Coloplast Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Altiform class III below knee stocking circular knit made to measure closed toe Soft beige (Altimed Ltd) 2 stocking VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SeaSorb Ag dressing 15cm x 15cm (Coloplast Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SeaSorb Ag dressing 15cm x 15cm (Coloplast Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melgisorb Ag dressing 15cm x 15cm (Molnlycke Health Care Ltd) 1 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Melgisorb Ag dressing 15cm x 15cm (Molnlycke Health Care Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Collagen dressing sachets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Potter's AllerClear tablets (Potter's (Herbal Supplies) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Potter's AllerClear tablets (Potter's (Herbal Supplies) Ltd) 84 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely nabilone 250 microgram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diflunisal 250mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium cromoglicate 10mg/ml nebuliser liquid 2ml unit dose vials (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium cromoglicate 10mg/ml nebuliser liquid 2ml unit dose vials 1 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diflunisal 250mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diflunisal 250mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium cromoglicate 10mg/ml nebuliser liquid 2ml unit dose vials (Special Order) 1 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lassar's paste (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lassar's paste (Special Order) 1 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Dermovate-NN cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Dermovate-NN ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benylin Dry Coughs Blackcurrant oral solution (McNeil Products Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glycerin and Blackcurrant linctus (The Boots Company Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nirolex Dry Cough linctus (The Boots Company Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Bristol Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Bristol Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Bristol Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glycerol 750microlitres/5ml / Sucrose 1.7g/5ml oral solution 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydroquinone 4% cream 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benylin Dry Coughs Blackcurrant oral solution (McNeil Products Ltd) 150 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glycerin and Blackcurrant linctus (The Boots Company Plc) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nirolex Dry Cough linctus (The Boots Company Plc) 150 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Bristol Laboratories Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Bristol Laboratories Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Bristol Laboratories Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 100mg powder for solution for infusion vials (Viatris UK Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 50mg powder for solution for infusion vials (Viatris UK Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 100mg powder for solution for infusion vials (Viatris UK Healthcare Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 50mg powder for solution for infusion vials (Viatris UK Healthcare Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely pentosan polysulfate sodium 100 milligram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Analog MSUD powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Analog XPhen Tyr powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic XPhen Tyr Met Analog powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic XMet Analog powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Analog XMet Thre Val Isoleu powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic XP Analog powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Perindopril 4mg / Indapamide 1.25mg tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Neomycin 0.5% cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lexon (UK) Ltd) 21 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lasilactone capsules (Lexon (UK) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nootropil 1.2g tablets (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Piracetam 1.2g tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lasilactone capsules (Lexon (UK) Ltd) 30 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nootropil 1.2g tablets (Lexon (UK) Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Waymade Healthcare Plc) 21 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lancets sterile single use 0.31mm/30gauge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely phenylbutazone 100 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nicotine 1.5mg lozenges sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 21 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride Meltdown 1500mg chewable tablets (IXL Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lasilactone capsules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride Meltdown 1500mg chewable tablets (IXL Pharma Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lasilactone capsules (Mawdsley-Brooks & Company Ltd) 30 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 32 of 86 Next End

This concept is not in any reference sets

Back to Start